VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study

Mikko T. Visuri, Krista M. Honkonen, Pauliina Hartiala, Tomi V. Tervala, Paavo J. Halonen, Heikki Junkkari, Nina Knuutinen, Seppo Yla-Herttuala, Kari K. Alitalo, Anne Saarikko

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalAngiogenesis
Volume18
Issue number3
Pages (from-to)313-326
Number of pages14
ISSN0969-6970
DOIs
Publication statusPublished - Jul 2015
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Lymphedema
  • Lymphangiogenesis
  • Angiogenesis
  • VEGF-C
  • VEGF-C156S
  • FACTOR RECEPTOR-3
  • BREAST-CANCER
  • NODE TRANSFER
  • POSTMASTECTOMY LYMPHEDEMA
  • LYMPHATIC ENDOTHELIUM
  • VESSEL ENLARGEMENT
  • TYROSINE KINASES
  • GENE-TRANSFER
  • ANGIOGENESIS
  • EXPRESSION
  • 3121 Internal medicine

Cite this

Visuri, M. T., Honkonen, K. M., Hartiala, P., Tervala, T. V., Halonen, P. J., Junkkari, H., Knuutinen, N., Yla-Herttuala, S., Alitalo, K. K., & Saarikko, A. (2015). VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study. Angiogenesis, 18(3), 313-326. https://doi.org/10.1007/s10456-015-9469-2